Diagnosing the Right Fit: A Clinical Breakdown of Parasitic Conditions Treated With Ivermectin in the US
Ivermectin holds FDA approval for a specific set of parasitic infections, yet confusion persists about when this medication is truly the appropriate clinical choice. This guide examines the approved indications—scabies, onchocerciasis, and strongyloidiasis—alongside the patient presentations that warrant its use. Understanding these distinctions helps patients engage more meaningfully with their healthcare providers.